• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
In the last 2 hours
In the last 7 days
In the last month
Immix Biopharma 12 Month Review Progress Update GlobeNewswire (Press Release)14:33 21-Feb-24
WVU Medicine Health Report: CAR-T Cell Therapy WDTV NewsChannel Five, West Virginia19:46 20-Feb-24
Novel immunotherapy approved for melanoma European Pharmaceutical Review18:07 19-Feb-24
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells Behavioural and Social Sciences at Nature Research09:46 16-Feb-24
Galapagos presents at EBMT-EHA annual meeting 2024 GlobeNewswire (Press Release)21:02 15-Feb-24
The AI-Driven CAR-T Design Arrives Behavioural and Social Sciences at Nature Research04:54 12-Feb-24
BioNTech partners with Autolus to advance CAR-T therapies Pharmaceutical Technology09:32 9-Feb-24
HemoGenyx Pharma soars on FDA trial consent Proactive Investors (UK)09:21 9-Feb-24
CAR-T cell therapy hope for cancer Bangalore Mirror00:55 9-Feb-24
CRM Nepal conducts lab test of CAR-T cell therapy The Kathmandu Post01:53 4-Feb-24
Cancer patients who are running out of hope to be offered ‘revolutionary’ treatment St George's University Hospitals NHS Foundation Trust (Press Release)10:37 2-Feb-24
Automated CAR-T Manufacturing Moves toward the Marketplace Genetic Engineering and Biotechnology News18:06 31-Jan-24
Keep calm and CAR-T on? BioSpace14:51 31-Jan-24
Oricell’s OriCAR-017 application secures FDA IND clearance Pharmaceutical Business Review12:06 30-Jan-24
view more headlines
29 Feb 14:35

About our CAR-T news

Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.